Multi-Functional Magnetic Nanocrystals for Tumor Mitochondria-Targeted Magnetic Hyperthermia Combined with Enhanced...

Area of Science:

• Biomaterials Science
• Nanotechnology
• Cancer Therapeutics

Background:

• Developing advanced nanomaterials for integrated cancer diagnosis and therapy is crucial.
• Targeted drug delivery systems can improve therapeutic efficacy and reduce side effects.
• Magnetic hyperthermia and radiotherapy are promising cancer treatment modalities.

Purpose of the Study:

• To synthesize and characterize a fluorescent magnetic nanomaterial (FDLI) with mitochondrial targeting properties.
• To investigate the potential of FDLI-mediated targeted magnetic hyperthermia (TMH) in enhancing tumor sensitivity to radiotherapy (RT).
• To elucidate the underlying mechanisms of FDLI's anti-tumor effects and RT sensitization.

Main Methods:

• FDLI was synthesized and characterized for its structural, magnetic, optical, and enzymatic properties.
• In vitro studies using 4T1 breast cancer cells assessed mitochondrial targeting, anti-tumor efficacy, and RT sensitization.
• In vivo studies in a subcutaneous breast tumor mouse model evaluated therapeutic effectiveness and optimized treatment protocols.

Main Results:

• FDLI successfully targeted tumor cell mitochondria, inducing localized TMH and generating hydroxyl radicals (·OH) via peroxidase-like activity.
• Mitochondrial disruption led to reduced ATP production, increased lipid peroxidation, elevated ROS, and decreased GSH, promoting ferroptosis.
• FDLI significantly enhanced tumor cell sensitivity to synergistic radiotherapy.

Conclusions:

• FDLI effectively inhibits tumor growth and metastasis by combining TMH and RT, prolonging survival in tumor-bearing mice.
• The study provides a strong clinical basis for FDLI as a high-performance agent for integrated tumor diagnosis and therapy.